Randomized trial to study efficacy of a 20% and 10% Hippophae rhamnoides containing creme used by patients with mild to intermediate atopic dermatitis;Uberprufung der wirksamkeit einer 20%igen und 10%igen sanddornkernolcreme bei patienten mit leichter bis mittelgradiger atopischer dermatitis

Aktuelle Dermatologie

Volumn 26, Issue 8-9, 2000, Pages 285-290

  Thumm, E J ^a   Stoss, M ^a   Bayerl, C ^a   Schurholz, Th ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIPPOPHAE RHAMNOIDES EXTRACT; MIGLYOL; PLACEBO; SATURATED FATTY ACID;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; DRY SKIN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOISTURE; PROSPECTIVE STUDY; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORAD INDEX; SCORING SYSTEM; SKIN CARE; SKIN WATER LOSS; TREATMENT OUTCOME;

EID: 0033797756     PISSN: 03402541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Efficacy of gamma-linolenic acid in the treatment of patients with atopic dermatitis
2. Atopic dermatitis
3. Sanddornole-ein neues Lipid fur die Kosmetik
4. Changes in the physical properties of the stratum corneum following treatment with glycerol
5. Neurodermitis-praventive und therapeutische strategien einer umweltdermatose
6. Placebo controlled trial of essential fatty acid supplementation in atopic dermatitis
7. Gamma-linolenic-acid-rich borage seed oil capsules in children with atopic dermatitis. A placebo controlled double-blind study
8. Die systemische therapie im behandlungskonzept des atopischen ekzems
9. The use of azathioprin in severe adult atopic eczema
10. Illness and social status - The special case of neurodermatitis
11. Psychobiologische aspekte der atopischen dermatitis
12. Cyclosporin in severe, therapy-resistant atopic dermatitis
13. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis
14. Recent epidemiological and genetic studies in atopic dermatitis
15. Prevalence and severity of bronchial asthma, allergic rhinitis and atopic dermatitis in Salzburg school children
16. Treatment of atopic dermatitis: A comparison of psychological and dermatological approaches to relapse prevention
17. Interferon-gamma therapy reduces blood leukozyte levels in patients with atopic dermatitis: Correlation with clinical improvement
18. Severity Scoring of Atopic Dermatitis: The SCORAD-Index
19. Epidermal barrier in disorders of the skin
20. Dermatology Life Quality Index (DLQI) - A simple practical measure for routine clinical use
21. Effect of topically applied evening primrose oil on epidermal barrier function in atopic dermatitis as a function of vehicle
22. Cyclosporin in atopic dermatitis: Time to relapse and effect of intermittent therapy
23. Phototherapy for atopic eczema with narrow-band UVB
24. Diagnostic features of atopic dermatitis
25. Electrical measurement of the water content of the stratum corneum in vivo and in vitro under various conditions: Comparison between skin surface hygrometer and corneometer in evaluation of the skin surface hydration state
26. Double-blind, multicenter analysis of the efficacy of borage oil in patients with atopic eczema
27. The applicability of clinical scoring systems: SCORAD and PASI in atopic and psoriatic dermatitis
28. Erbprognose in der Dermatologie
29. Dermatologie
30. Dermatologie
31. Doppelblinde placebo-kontrollierte Studie zur Bedeutung der topischen Anwendung mehrfach ungesattigter Fettsauren fur die Barrierefunktion der Epidermis
32. The influence of cultural and educational factors on the validity of symptom and diagnosis questions for atopic eczema
33. High dose UVA-1 therapy for atopic dermatitis: Results of a multicenter trial
34. A new in vitro method for transepidermal water loss: A possible method for moisturizer evaluation
35. Improvement of skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream
36. Biophysical properties of dry atopic and normal skin with special reference to effects of skin care products
37. Skin susceptibility of atopic individuals
38. Evaluation einer stationaren psychotherapeutisch-dermatologischen Behandlung bei Neurodermitispatienten
39. Association between genetic variants of mast-cell chymase and eczema
40. Optimization of physiological lipid mixtures for barrier repair
41. Prevention of model stratum corneum lipid phase transitions in vitro by cosmetic additives - Differential scanning calometry, optical microscopy and water evaporation studies
42. Dietary supplementation with ethyl ester concentrates of fish oil and borage oil polyun-saturated fatty acids induces epidermal generation of local putative antinflammatory metabolites
43. Atopic dermatitis and birth factors: Historical follow up by record linkage
44. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis
45. Neurodermitis im Kindesalter. Differenzial-diagnose-Komplikationen-Therapie
46. Prognose und Behandlungserfolg bei stationarer psychotherapeutisch-dermatologischer Behandlung von Neurodermitispatienten
47. Sanddornlipide-interessante Wirkstoffe fur die Kosmetik
48. The biological effect of glycerol
49. Atopic dermatitis: An update
50. A short-term trial of tacrolimus ointment for atopic dermatitis
51. Das atopische Ekzem
52. Das integrierte Therapiekonzept des atopischen Ekzems
53. Atopic eczema and other manifestations of atopy: Results of a study in East and West Germany
54. Fettbegleitstoffe des Sanddornols
55. Value of adjuvant basic therapy in chronic recurrent skin diseases. Neurodermatitis atopica/psoriasis vulgaris
56. The occurrence of atopic dermatitis in north Europe: An international questionnaire study
57. Zur Praxis der Verhaltenstherapie bei dermatologischen Storungen
58. A double-blind comparison of two creams containing urea as the active ingredient. Assessment of efficacy and side effects by non-invasive techniques and clinical scoring scheme
59. The precipitation of symptoms by common foods in children with atopic dermatitis
60. Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels
61. Summary of the 1st Georg Rajka Symposium 1998 and a Literature Review
62. Sanddorn in der russischen Medizin
63. Susceptibility to irritants: Role of barrier function, skin dryness and history of atopic dermatitis
64. Dermatologic climate therapy-definition, indications and public health necessity
65. Genetik der Neurodermitis
66. Atopic eczema: How to tackle the most common atopic symptom
67. Metabolism of topically applied fatty acid methyl esters in BALB/C mouse epidermis
68. Epidemiology and natural history of atopic dermatitis